Active

OMRIX BIOPHARMACEUTICALS

Switched

BE0455883073

Rechtspersoon Naamloze vennootschap 1 establishment

Active for

30 year, 7 months

Registered office

Leonardo da Vincilaan 15

1831 Machelen (Brab.)

België

Names & denominations

OMRIX BIOPHARMACEUTICALS

Official name

NL

Enterprise details

Enterprise type

Rechtspersoon

Legal form

Naamloze vennootschap

Legal situation

Normale toestand

Start date

31 August 1995

Contact

Not specified

Peppol

Active
0208:0455883073

Active since 18 Dec 2025

Powered by

Databakkes.be

Company info. No nonsense.

Activities

NACE-BEL activity descriptions are currently shown in Dutch. English translations are underway.

NACE-BEL activities

What does this company officially do?

70100 Main activity

Activiteiten van hoofdkantoren

74152 Main activity

Coördinatiecentra

51460 Main activity

Groothandel in farmaceutische producten

46460 Main activity

Groothandel in farmaceutische en medische artikelen

What are NACE codes? NACE-BEL is the Belgian version of the European activity nomenclature. Each company has at least one code indicating its main activity.

Establishments

Establishment units

Physical locations of this company

Registered office

Leonardo da Vincilaan 15

1831 Machelen (Brab.)

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Frequently asked questions

What is the enterprise number of OMRIX BIOPHARMACEUTICALS?
The enterprise number of OMRIX BIOPHARMACEUTICALS is BE0455883073.
What is the address of OMRIX BIOPHARMACEUTICALS?
The registered office of OMRIX BIOPHARMACEUTICALS is located at Leonardo da Vincilaan 15, 1831 Machelen (Brab.).
When was OMRIX BIOPHARMACEUTICALS founded?
OMRIX BIOPHARMACEUTICALS was founded on 31 August 1995.
What is the main activity of OMRIX BIOPHARMACEUTICALS?
The main activity of OMRIX BIOPHARMACEUTICALS is "Activiteiten van hoofdkantoren" (NACE code 70100).
Does OMRIX BIOPHARMACEUTICALS have a website?
No website is currently known for OMRIX BIOPHARMACEUTICALS.